![](/img/cover-not-exists.png)
P201 Subcutaneous versus intravenous trastuzumab in early breast cancer: 2-year follow-up of HannaH
Jackisch, C., Hegg, R., Stroyakovskiy, D., Ahn, J., Melichar, B., Chen, S.C., Crepelle-Flechais, A., Heinzmann, D., Shing, M., Pivot, X.Volume:
24
Language:
english
Journal:
The Breast
DOI:
10.1016/S0960-9776(15)70235-3
Date:
March, 2015
File:
PDF, 55 KB
english, 2015